Related Experiment Video
Updated: Jun 20, 2025
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
Improving Collection and Analysis of Overall Survival Data
Lisa R Rodriguez1, Nicole J Gormley1, Ruixiao Lu2,3
1U.S. Food and Drug Administration, Silver Spring, Maryland.
Summary
Improving cancer care requires robust overall survival (OS) data in clinical trials. This study proposes best practices for collecting and analyzing OS to better assess the true benefit-risk of new anticancer therapies.
Area of Science:
- Oncology
- Clinical Trial Design
- Biostatistics
Background:
- Anticancer therapies have improved patient survival, but challenges remain in evaluating new treatments.
- Overall survival (OS) is the gold standard endpoint, but reliance on earlier endpoints may not correlate with OS.
- Inadequate OS data collection in trials complicates benefit-risk assessments for novel cancer therapies.
Purpose of the Study:
- To highlight the importance of rigorous overall survival (OS) data in cancer clinical trials.
- To propose statistical methodologies and best practices for improving OS data collection and analysis.
- To enhance the evaluation of benefit-risk for novel anticancer therapies.
Main Methods:
- Review of current practices in cancer clinical trial endpoint selection.
- Proposal of best practices for prospective OS data collection.
- Recommendations for defining OS detriment and prespecifying OS analysis plans.
Main Results:
- Many registrational trials lack adequate planning for OS data collection and analysis.
- Improved OS data rigor is crucial for accurate benefit-risk assessments.
- Novel statistical approaches can enhance the evaluation of OS data.
Conclusions:
- Strengthening the collection and analysis of overall survival (OS) data is essential for cancer drug development.
- Implementing proposed best practices will improve the interpretation of novel therapy benefits and risks.
- Enhanced OS data utilization supports informed regulatory decisions and patient care.
Related Concept Videos
01:21Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
01:24Kaplan-Meier Approach
119
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
119
01:20Comparing the Survival Analysis of Two or More Groups
170
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
170
01:15Assumptions of Survival Analysis
119
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
119
01:18Introduction To Survival Analysis
203
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
203
01:20Actuarial Approach
71
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
71